HQL

abrdn Life Sciences Investors
HQL

Overview Fund Trends Analyst Outlook Journalist POV

49 hedge funds and large institutions have $43.4M invested in abrdn Life Sciences Investors in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 17 increasing their positions, 18 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
49
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$959K
2
+$807K
3
+$521K
4
NIM
Needham Investment Management
New York
+$258K
5
UCFA
United Capital Financial Advisors
Texas
+$195K

Top Sellers

1
-$2.11M
2
-$1.23M
3
-$848K
4
Wells Fargo
Wells Fargo
California
-$769K
5
UBS Group
UBS Group
Switzerland
-$643K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$195K
27
$189K
28
$183K
29
$135K
30
$58K
31
$56K
32
$31K
33
$21K
34
$21K
35
$19K
36
$18K
37
$17K
38
$12K
39
$9K
40
$7K
41
$5K
42
$1K
43
$1K
44
$1K
45
–
46
–
47
–
48
–
49
–
50
–
1
2